Screening compound: InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H

Screening compound: InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H
Screening compound: InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D727-0738

Molecular Formula

C18H11N5S (C18 H11 N5 S)

Compound Name

2-{6-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-3-yl}quinoline

IUPAC name

2-{6-phenyl-[124]triazolo[34-b][134]thiadiazol-3-yl}quinoline

SMILES

c(cc1)ccc1-c(s1)nn2c1nnc2-c1nc2ccccc2cc1

InChI

InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H

InChI Key

WOHSMYBTLCVKAH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09850924

InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Targeted Diversity Library (40567 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H?
Check Price and Availability of InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H11N5S/c1-2-7-13(8-3-1)17-22-23-16(20-21-18(23)24-17)15-11-10-12-6-4-5-9-14(12)19-15/h1-11H available by request